Back
Pacira Biosciences, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
PCRX
Pacira Biosciences, Inc.
Last Price:
$21.91
Seasonality Move:
4.18%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PCRX is experiencing slight selling pressure.
Pacira Biosciences, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.09 | Sell |
| 20-day SMA: | 21.85 | Buy |
| 50-day SMA: | 22.99 | Sell |
| 200-day SMA: | 23.92 | Sell |
| 8-day EMA: | 19.13 | Buy |
| 20-day EMA: | 11.65 | Buy |
| 50-day EMA: | 5.65 | Buy |
| 200-day EMA: | 1.56 | Buy |
Pacira Biosciences, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.3 | Buy |
| Relative Strength Index (14 RSI): | 52.66 | Buy |
| Chaikin Money Flow: | -716035 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.41 - 22.71) | Buy |
| Bollinger Bands (100): | (21.19 - 24.97) | Sell |
Pacira Biosciences, Inc. Technical Analysis
| Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 12 | 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pacira Biosciences, Inc. Stock
Is Pacira Biosciences, Inc. Stock a Buy?
-
Pacira Biosciences, Inc. share price is 22.59 while PCRX 8-day simple moving average is 23.09, which is a Sell signal.
-
The stock price of PCRX is 22.59 while Pacira Biosciences, Inc. 20-day SMA is 21.85, which makes it a Buy.
-
Pacira Biosciences, Inc. 50-day simple moving average is 22.99 while PCRX share price is 22.59, making it a Sell technically.
-
PCRX stock price is 22.59 and Pacira Biosciences, Inc. 200-day simple moving average is 23.92, creating a Sell signal.
PCRX Technical Analysis vs Fundamental Analysis
Sell
41
Pacira Biosciences, Inc. (PCRX)
is a Sell
Is Pacira Biosciences, Inc. a Buy or a Sell?
-
Pacira Biosciences, Inc. stock is rated a SellThe current Pacira Biosciences, Inc. [PCRX] share price is $22.59. The Score for PCRX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Pacira Biosciences, Inc. Stock Info
Market Cap:
971.9M
Price in USD:
22.59
Share Volume:
2.1M
Pacira Biosciences, Inc. 52-Week Range
52-Week High:
27.64
52-Week Low:
18.80
Sell
41
Pacira Biosciences, Inc. (PCRX)
is a Sell
Pacira Biosciences, Inc. Share Price Forecast
-
What is the Pacira Biosciences, Inc. stock price today?The Pacira Biosciences, Inc. stock price is 22.59 USD today.
-
Will PCRX stock go up or go down?Pacira Biosciences, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Pacira Biosciences, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pacira Biosciences, Inc. is overvalued.
Is Pacira Biosciences, Inc. Stock a Buy?
-
Pacira Biosciences, Inc. share price is 22.59 while PCRX 8-day exponential moving average is 19.13, which is a Buy signal.
-
The stock price of PCRX is 22.59 while Pacira Biosciences, Inc. 20-day EMA is 11.65, which makes it a Buy.
-
Pacira Biosciences, Inc. 50-day exponential moving average is 5.65 while PCRX share price is 22.59, making it a Buy technically.
-
PCRX stock price is 22.59 and Pacira Biosciences, Inc. 200-day simple moving average is 1.56, creating a Buy signal.
Fundamental Analysis of Pacira Biosciences, Inc.
Is Pacira Biosciences, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.32 per share.
Technical Analysis of Pacira Biosciences, Inc.
Should I short Pacira Biosciences, Inc. stock?
-
PCRX Moving Average Covergence Divergence (MACD) indicator is 6.3, suggesting Pacira Biosciences, Inc. is a Buy
-
Pacira Biosciences, Inc. Relative Strength Index (RSI) is 52.66, which suggest Pacira Biosciences, Inc. is overbought
-
The Bollinger Bands (25) for Pacira Biosciences, Inc. is (20.41 - 22.71), which suggest Pacira Biosciences, Inc. is a Sell
-
The Bollinger Bands (100) for Pacira Biosciences, Inc. is (21.19 - 24.97), which suggest Pacira Biosciences, Inc. is a Sell
* Pacira Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.